Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer
{{output}}
Liver fibrosis and biological sex variably modulate the risks of hepatocellular carcinoma (HCC) and extrahepatic cancers (EHCs) arising in the context of metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we highlight how these variables m... ...
